Arsene Jaures Ouemba Tasse | Biomedical and Healthcare Applications | Best Researcher Award

Dr . Arsene Jaures Ouemba Tasse | Biomedical and Healthcare Applications | Best Researcher Award

Postdoc at University of the Witwatersrand, Johannesburg, South Africa

Dr. Arsène Jaures Ouemba Tasse is a dynamic Postdoctoral Research Fellow at the University of the Witwatersrand, South Africa, with a specialized focus in applied dynamical systems and mathematical modeling of infectious diseases. He holds a Ph.D. in Mathematics from the University of Dschang, Cameroon, and has published extensively in high-impact journals on topics including Ebola, COVID-19, Typhoid, and Monkeypox. His research contributions have global significance, particularly in understanding disease transmission dynamics and control strategies. Dr. Ouemba Tasse has participated in numerous international conferences, received prestigious research grants, and supervised both undergraduate and postgraduate students. He is also an active reviewer for several scientific journals and has contributed to collaborative projects funded by renowned institutions like the Bill & Melinda Gates Foundation. His growing leadership in academic events, combined with his commitment to public health through mathematics, positions him as a highly influential figure in the field of mathematical epidemiology.

Professional Profile 

Education🎓 

Dr. Arsène Jaures Ouemba Tasse has a strong academic foundation in mathematics, beginning with a Bachelor’s degree from the University of Yaoundé I in 2009. He pursued his Honours and Master’s degrees in Mathematics at the University of Dschang, Cameroon, where he graduated with distinction. His academic journey culminated in earning a Ph.D. in Applied Dynamical Systems and Mathematical Modeling from the same institution in 2021. His doctoral studies equipped him with advanced knowledge in differential equations, epidemiological modeling, partial differential equations, and numerical analysis. Additionally, he obtained a Secondary and High School Teacher’s Diploma in Mathematics from the Higher Teacher’s Training College of Yaoundé in 2008, highlighting his early commitment to education. To enhance his international research engagement, he completed an English language course at the University of the Witwatersrand in 2023. His academic pathway reflects both depth and breadth in mathematical sciences, with a strong emphasis on applied research for real-world impact.

Professional Experience📝

Dr. Ouemba Tasse brings over 15 years of professional experience in teaching, research, and academic mentorship. Since November 2022, he has served as a Postdoctoral Research Fellow at the University of the Witwatersrand, Johannesburg, where he engages in cutting-edge research, student supervision, and academic event organization. Before this, he spent over a decade teaching mathematics in various high schools in Cameroon, including the General High School Tsela and the General Bilingual High School Bameka. His university-level experience includes lecturing and tutoring in courses such as algebra, calculus, mathematical modeling, and discrete population dynamics. He has participated in academic panels, supervised postgraduate research groups, and served as an external examiner. His professional journey reflects a seamless transition from secondary education to advanced research, demonstrating versatility, leadership, and commitment to educational excellence in both national and international academic environments.

Research Interest🔎

Dr. Ouemba Tasse’s research interests are centered around mathematical epidemiology, applied dynamical systems, and optimal control theory, particularly in the context of infectious disease modeling. He focuses on developing and analyzing mathematical models that simulate the transmission dynamics of diseases such as Ebola, COVID-19, Typhoid, Malaria, Monkeypox, and HIV. His models incorporate various control strategies including awareness programs, vaccination, isolation, and traditional versus modern treatment methods. He also works on the mathematical formulation and numerical solutions using nonstandard finite difference schemes that ensure stability and accuracy in epidemic simulations. His recent projects explore the co-dynamics of multiple infections and the role of environmental and behavioral factors in disease propagation. Additionally, he is interested in the intersection of public health and mathematics, including modeling cancer progression and mother-to-child HIV transmission. His interdisciplinary approach bridges mathematical theory and health policy, offering vital insights for effective disease control and healthcare intervention strategies.

Award and Honor🏆

Dr. Ouemba Tasse has received numerous accolades and support from prestigious institutions for his impactful research in mathematical modeling. He was awarded a Postdoctoral Fellowship by the University of the Witwatersrand, along with funding from the Bill & Melinda Gates Foundation for a cervical cancer modeling project. He received full sponsorships from the Simons Foundation and the Pacific Institute of Mathematical Sciences to attend international conferences and research schools in Canada and the USA. He won first prize in Analysis at a postgraduate workshop in Cameroon and was a recipient of the Humboldt Foundation’s funding during the Dschang Humboldt Kolleg. His academic excellence has been further recognized through grant awards from the Society for Mathematical Biology and participation in global conferences like BIOMATH and CIMPA. These honors not only acknowledge his research excellence but also reflect his growing reputation as a leading contributor to mathematical modeling in epidemiology and public health.

Research Skill🔬

Dr. Ouemba Tasse possesses advanced research skills in both theoretical and computational aspects of applied mathematics. He is proficient in developing deterministic and stochastic models of infectious diseases, applying optimal control techniques, and performing stability analysis of equilibrium states. His expertise in nonstandard finite difference schemes enhances the accuracy and robustness of numerical simulations. He is well-versed in software tools such as MATLAB, MATHEMATICA, R, and LaTeX, which he uses extensively for simulations, data analysis, and scientific writing. His research includes data fitting and parameter estimation, and he has applied these techniques in real-world epidemiological studies. He also has strong collaborative skills, having led and co-supervised numerous multidisciplinary projects and study groups. Additionally, he contributes as a peer reviewer for reputed journals and book chapters, showcasing his analytical precision and subject-matter authority. These combined skills make him an adept and resourceful researcher capable of addressing complex public health challenges through mathematics.

Conclusion💡

Dr. Arsène Jaures Ouemba Tasse is a highly promising and competitive candidate for the Best Researcher Award, especially in fields involving epidemiological modeling, applied mathematics, and computational public health. His international exposure, robust publication record, academic mentoring, and societal relevance of his research make him exceptionally well-qualified for this honor.

While still in an early career stage, his trajectory shows exemplary leadership potential and deep scholarly contributions. With minor improvements such as increasing PI roles and broader interdisciplinary outreach, he would not only be eligible but also a standout award recipient.

Publications Top Noted✍

  1. Title: Mathematical modeling of contact tracing as a control strategy of Ebola virus disease
    Authors: T. Berge, A.J. Ouemba Tassé, H.M. Tenkam, J. Lubuma
    Year: 2018
    Citations: 34

  2. Title: Dynamics of host-reservoir transmission of Ebola with spillover potential to humans
    Authors: B. Tsanou, J.M.S. Lubuma, A.J.O. Tassé, H.M. Tenkam
    Year: 2018
    Citations: 22

  3. Title: Ebola virus disease dynamics with some preventive measures: a case study of the 2018–2020 Kivu outbreak
    Authors: A.J. Ouemba Tasse, B. Tsanou, J. Lubuma, J.L. Woukeng, F. Signing
    Year: 2022
    Citations: 6

  4. Title: Nonstandard finite difference schemes for some epidemic optimal control problems
    Authors: A.J.O. Tassé, V.B. Kubalasa, B. Tsanou
    Year: 2025
    Citations: 2

  5. Title: A metapopulation model with exit screening measure for the 2014–2016 West Africa Ebola virus outbreak
    Authors: A.J.O. Tassé, B. Tsanou, J.L. Woukeng, J.M.S. Lubuma
    Year: 2024
    Citations: 1

  6. Title: A mathematical model to study herbal and modern treatments against COVID-19
    Authors: A.J. Ouemba Tassé, B. Tsanou, C. Kwa Kum, J. Lubuma
    Year: 2024
    Citations: 1

  7. Title: Assessment of effective isolation, safe burial and vaccination optimal controls for an Ebola epidemic model
    Authors: A.J.O. Tassé, B. Tsanou, J.M.S. Lubuma, J.L. Woukeng
    Year: 2020
    Citations: 1

  8. Title: Mathematical modelling of the dynamics of typhoid fever and two modes of treatment in a Health District in Cameroon
    Authors: T.J. Tsafack, C.K. Kum, A.J.O. Tassé, B. Tsanou
    Year: 2025

  9. Title: A mathematical model on the impact of awareness and traditional medicine in the control of Ebola: case study of the 2014–2016 outbreaks in Sierra Leone and Liberia
    Authors: A.J. Ouemba Tassé, B. Tsanou, C.K. Kum, J. Lubuma
    Year: 2024

  10. Title: Influence of the co-dynamics Ebola-COVID-19 in the population
    Authors: A.J.O. Tassé, J. Lubuma, B. Tsanou
    Year: 2023

  11. Title: Investigating the impact of isolation, self-isolation and environmental transmission on the spread of COVID-19: case study in Rwanda
    Authors: J.M.S. Lubuma, A.J.O. Tassé, F. Signing, B. Tsanou
    Year: 2023

  12. Title: Modélisation mathématique de la transmission de la maladie à virus Ebola et stratégies de contrôle
    Authors: A.J.O. Tasse
    Year: 2021

  13. Title: Mathematical modeling of contact tracing as a control strategy of Ebola virus disease (Duplicate entry)
    Authors: B. Tsanou, A.J. Ouemba Tassé, H.M. Tenkam, J.M.S. Lubuma
    Year: 2018

  14. Title: Investigating the impact of isolation, self-isolation and environmental transmission on the spread of COVID-19: case study of Rwanda (Duplicate entry)
    Authors: M.S.L. Jean, A.J.O. Tassé, F. Signing, B. Tsanou
    Year: 2023

Dr. Rainer Hubmann | Biomedical and Healthcare Applications | Best Researcher Award

Dr. Rainer Hubmann | Biomedical and Healthcare Applications | Best Researcher Award

Doctorate at Red Cross | Austria

Mag. Dr. Rainer Hubmann embarked on his academic journey at the University of Vienna, earning his master’s degree in Biology/Genetics in 1996. During this time, he became an active member of the Cell Cycle Club under the leadership of Kim Nasmyth at the Research Institute of Molecular Pathology (IMP). His passion for molecular biology led him to pursue his Ph.D. at the Medical University of Vienna, where he focused on the regulation of CD23 in Chronic Lymphocytic Leukemia (CLL), completing it in 2002.

Professional Profiles

Scopus

Orcid

🎓Education and Academic Background

Dr. Rainer Hubmann’s distinguished academic journey began at the University of Vienna, where he earned a Master’s degree in Biology and Genetics (1987–1996). During this time, he joined the prestigious Cell Cycle Club, led by Kim Nasmyth, sharpening his focus on cell cycle research. He pursued his Ph.D. thesis (1997–2002) at the Medical University of Vienna (MUW), investigating the Regulation of CD23 in Chronic Lymphocytic Leukemia (CLL). His postdoctoral work from 2002 to 2011 extended into pioneering studies on NOTCH2 regulation and the characterization of CLL stem cells. In 2022, he assumed the role of Group Leader and Senior Scientist at the Division of Hematology and Hemostaseology, MUW, further solidifying his leadership in hematological research.

🔬 Research and Innovation

Dr. Hubmann’s research has made groundbreaking strides in NOTCH signaling and its implications in cancer. His work elucidates the central role of NOTCH2 signaling in CLL leukemogenesis, uncovering vital mechanisms of disease progression. He has identified GLIOTOXIN as a potent therapeutic NOTCH2/CSL transactivation inhibitor, presenting it as a promising alternative to conventional γ-secretase inhibitors. Furthermore, he discovered a tumor-suppressor role for NOTCH3 signaling in CLL, revealing its therapeutic potential. Dr. Hubmann’s studies have highlighted the recurring NOTCH2ΔNRR gain-of-function (GOF) mRNA deletions as potentially disease-defining genetic lesions in CLL. His innovative research also explores somatic recombination involving ancient and recent NOTCH2 gene variants, addressing hereditary, geographic, and gender-based variations.

🧪 Patents and Innovations

Dr. Hubmann’s contributions to translational medicine are protected by several patents. These include Gliotoxin for the treatment of NOTCH2-associated malignancies (WO/2006/135949; US Patent No 7,981,878) and NOTCH21A01/1a4-RFLP as a leukemia/tumor predisposition detection tool (MUW Tech-ID: 835.19). His patented innovations underscore his role in translating basic research into clinical applications.

💡 Technical Expertise

Dr. Hubmann possesses advanced technical skills pivotal to hematology and oncology research. His expertise includes gene expression and silencing techniques such as retroviral vectors and siRNA-mediated gene silencing. He is proficient in molecular analysis, including RT-PCR, Northern & Western blotting, and RNA-seq sequence analysis. His work extends to drug screening models, xenograft mouse models, and developing diagnostic tools for personalized medicine. His ability to blend bioinformatics with preclinical studies further enhances his contributions to the field.

💵 Funding and Grants

Over his career, Dr. Hubmann has secured significant funding for his research. Notable grants include FWF P15100 (2001) for studying the Regulation and Function of NOTCH2 in CLL, and ÖNB Jubiläumsfonds (2002, 2004) for exploring NOTCH2 in leukemogenesis. His work on GLIOTOXIN’s therapeutic potential was supported by Initiative Krebsforschung (2013), while his recent studies on NOTCH2ΔNRR deletions were funded by the Fellinger Krebsforschungsfonds (2022). These funding milestones reflect the impact and importance of his research.

🏆 Awards and Recognition

Dr. Hubmann’s outstanding contributions to medical research have earned him numerous accolades. In 1999, he received the Aventis Stiftung Award for his work on fibroblast growth factor in Hairy Cell Leukemia. His innovative findings on interferon-alpha in Hairy Cell Leukemia earned the Erste Bank Preis in 2001. In 2005 and 2010, he was awarded the Sanofi-Aventis Prize for breakthroughs in cancer therapy and PI3-K/Akt/CK2 signaling. Additionally, the Paracelsus Medical University Award (2008) recognized his research on TGF-β in Radon therapy for Ankylosing Spondylitis patients.

🏢 Professional Memberships

Dr. Hubmann is an esteemed member of the Austrian Society for Hematology and Oncology (ÖGHO). He serves as the Vice Coordinator of the Comprehensive Cancer Center Vienna (CCC) Research Cluster, focusing on Microenvironment, Vasculature, and Metastasis, underscoring his leadership in advancing cancer research.

🎓 Teaching and Mentorship

Since 1998, Dr. Hubmann has played a pivotal role in teaching and mentoring young scientists. He leads specialized courses, including Molecular Biology in Hematology-Oncology and Clinical and Experimental Hematology, since 2001. His dedication extends to supervising Ph.D. and diploma students, nurturing the next generation of researchers and clinicians.

Publications Top Noted📚 

Targeting Nuclear NOTCH2 by Gliotoxin Recovers a Tumor-Suppressor NOTCH3 Activity in CLL Cells

Authors: Rainer Hubmann

Journal: Cells

Year: 2020

UGT2B17 modifies drug response in chronic lymphocytic leukaemia

Authors: Rainer Hubmann

Journal: British Journal of Cancer

Year: 2020

Combined approach for characterization and quality assessment of rabbit bone marrow-derived mesenchymal stem cells intended for gene banking

Authors: Rainer Hubmann

Journal: New Biotechnology

Year: 2020

Combined chemosensitivity and chromatin profiling prioritizes drug combinations in CLL

Authors: Rainer Hubmann

Journal: Nature Chemical Biology

Year: 2019

Critical assessment of the efficiency of CD34 and CD133 antibodies for enrichment of rabbit hematopoietic stem cells

Authors: Rainer Hubmann

Journal: Biotechnology Progress

Year: 2018

Mr. Ardak Kanagatovich Syzdykov | Healthcare Applications | Young Scientist Award

Mr. Ardak Kanagatovich Syzdykov | Healthcare Applications | Young Scientist Award

Ardak Kanagatovich Syzdykov at Institute of Organic Synthesis and Coal Chemistry, Kazakhstan 

Profile

Orcid

Academic Background

Mr. Ardak Kanagatovich Syzdykov is a dedicated and skilled chemical analyst and pharmacist. With a background in chemical technology and pharmacy, he is known for his strong work ethic, quick learning abilities, and effective communication skills. Ardak is highly motivated and committed to making significant contributions in his professional field.

Education

Mr. Ardak’s educational journey began at Ustobin Secondary School (2003-2014), followed by a degree in Pharmacy from Bolashak Higher Academy (2014-2019). He further advanced his expertise with a Master’s Degree in Chemical Technology of Organic Substances from Karaganda Technical University (2019-2021).

Professional Experience

Mr. Ardak has garnered valuable experience through various roles: Chemical Analyst at International Scientific and Production Holding “Fitokhimiya,” Laboratory Assistant Trainee at LLP “Natiyezh,” Pharmacist at LLP “Darysyn,” and Chemical Analyst at LLP “Pharmacy 2010.” His diverse experience underscores his expertise and adaptability in the field.

🛠️ Skills and Competencies

Mr. Ardak is proficient in using MS Office, email, internet browsers, and graphic programs. He excels in rapid information search on the internet and is fluent in Kazakh and Russian, with an A2 level in English. His personal traits include being a team player, quick learner, communicative, responsible, and conflict-free.

 Publications

Synthesis and Biological Activity of New Hydrazones Based on N-Aminomorpholine
  • Authors:Oralgazy Nurkenov, Saule B. Zhautikova, Andrei Khlebnikov, Ардақ Сыздықов, Serik D. Fazylov, Tulegen Seilkhanov, Saule K. Kabieva, Kobylandy M. Turdybekov, Anel Mendibayeva, Gaziza M. Zhumanazarova
  • Journal: Molecules
  • Year: 2024